MyDoc, South Asia’s leading telemedicine service aims to bring primary care to some of the region’s 400 million persons that have no access.
It has commenced a 6 country roll-out into the Philippines, Thailand, Malaysia, Vietnam and Indonesia notably under the aegis of the insurance companies Prudential and Aetna.
Telemedicine is now recognised as the safest and most effective way of getting access to medical professional without overburdening physical facilities and causing the potential spread of diseases. Given the current environment, the prospects for remote medicine are more compelling than ever.
Milltrust is seeking to close a convertible round of 2 million USD from professional investors only ahead of a 15-20 million USD B round in the coming months.
Contact us for more information: [email protected]
With a unique multi-local multi-affiliate structure, Milltrust provides innovative investment solutions where we can offer genuinely differentiated alpha to our investors around the globe. The firm operates in a regulated capacity across multiple jurisdictions including the UK, Singapore, Ireland, Cayman, and Mauritius. The primary affiliated businesses are: Milltrust International LLP and Milltrust Agricultural Investments.
For professional investors only. This document is strictly private and confidential and is meant as guidance and information only. It is issued by Milltrust International Group (Singapore) Pte Ltd, incorporated in Singapore. Milltrust International LLP is incorporated in the United Kingdom, which is authorised and regulated by the Financial Conduct Authority. Milltrust International LLP has its registered office at 5 Market Yard Mews, 194-204 Bermondsey Street, London, SE1 3TQ, United Kingdom and is a subsidiary of Milltrust International Group (Singapore) Pte Ltd. Milltrust Agricultural Investments Ltd is an affiliate of Milltrust International LLP. The content in this document is for informational purposes only and does not constitute legal, tax, investment, financial, or other advice. Nothing contained in this document constitutes a solicitation, recommendation, endorsement, or offer by Milltrust International Group (Singapore) Pte Ltd or any of its affiliates to buy or sell any securities or other financial instruments. No such solicitation or offer is made in this or in any other jurisdiction in which such solicitation or offer would be unlawful under the securities laws of such jurisdiction. All content in this document is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in the document constitutes professional and/or financial advice, nor does any information on the document constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. It should therefore not be used as the sole basis for any investment or other decision. The use of or access to this document or content by any person does not creat1e a fiduciary relationship between such person and Milltrust International Group (Singapore) Pte Ltd. The sole responsibility of evaluating the merits and risks associated with the use of any information or other content on this document before making any decisions based on such information or other content rests with the user and their professional advisers.
Categories: News
Tags: Healthcare